NMD Pharma Information | NMD Pharma Profile
NMD Pharma breder sig til nye områder før næste kapitalrejsning
NMD Pharma A/S | LinkedIn
Management team — NMD Pharma
NMD Pharma - Inkef capital
NMD Pharma - Inkef capital
NMD Pharma - PIR International
NMD Pharma Information | NMD Pharma Profile
NMD Pharma A/S | LinkedIn
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
PRESS RELEASE NMD Pharma Moves Corporate Headquarters to INCUBA to Support Future Growth
Thomas Holm Pedersen - Chief Executive Officer, Associate professor of Physiology and Biophysics in Aarhus, Arhus, Denmark | eMedEvents
Your career — NMD Pharma
Management team — NMD Pharma
Management team — NMD Pharma
NMD Pharma - Inkef capital
Idebenone as a novel, therapeutic approach for Duchenne muscular dystrophy: Results from a 12 month, double-blind, randomized pl
NMD Pharma A/S | LinkedIn
Thomas Holm Pedersen - Ownr.dk
NMD Pharma Doses the First Myasthenia Gravis Patient in a Combined Phase I/IIa Clinical Trial of NMD670 | Lifecarenews
NMD Pharma A/S | LinkedIn
Katja Krustrup Pedersen - Research Scientist and Project Manager - NMD Pharma | LinkedIn
Management team — NMD Pharma
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
Biotek-kometen NMD Pharma fortsætter vækstrejse i Aarhus
Management team — NMD Pharma
Your career — NMD Pharma
